|
[1]
|
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2022概要[J]. 中国循环杂志, 2023, 38(6): 583-612.
|
|
[2]
|
Ramji, D.P. and Davies, T.S. (2015) Cytokines in Atherosclerosis: Key Players in All Stages of Disease and Promising Therapeutic Targets. Cytokine & Growth Factor Reviews, 26, 673-685. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
王一波, 栾天竹. 单核细胞与高密度脂蛋白比值在心血管疾病中的研究进展[J]. 临床与病理杂志, 2022, 42(1): 226-231.
|
|
[4]
|
桑婉玥, 李红建. 单核细胞/高密度脂蛋白胆固醇比值在心血管疾病中的研究进展[J]. 海南医学院学报, 2021, 27(10): 797-800.
|
|
[5]
|
李国强, 韩清华, 陈小平. 全身免疫炎症指数与冠心病关系的研究进展[J]. 中西医结合心脑血管病杂志, 2024, 22(9): 1610-1614.
|
|
[6]
|
刘明波, 何新叶, 杨晓红, 等. 《中国心血管健康与疾病报告2023》要点解读[J]. 中国全科医学, 2025, 28(1): 20-38.
|
|
[7]
|
王敏, 李瑾. 炎性细胞在动脉粥样硬化中作用的研究进展[J]. 中国动脉硬化杂志, 2022, 30(3): 265-270.
|
|
[8]
|
胥雪莲, 何川. 炎症与动脉粥样硬化[J]. 心血管病学进展, 2015, 36(5): 634-637.
|
|
[9]
|
余嘉清, 韩敏, 朱兵, 等. 单核细胞与高密度脂蛋白胆固醇比值在心肌病发生和发展过程中的机制及研究进展[J]. 中国临床保健杂志, 2021, 24(5): 715-720.
|
|
[10]
|
孙沁瑜, 邓毅凡, 何胜虎, 等. 中性粒细胞/淋巴细胞比值、单核细胞/高密度脂蛋白胆固醇比值及两者联合对急性ST段抬高型心肌梗死患者急诊经皮冠状动脉介入治疗术后造影剂肾病的预测价值研究[J]. 中国全科医学, 2025, 28(15): 1891-1897
|
|
[11]
|
许璨. 3-HPA通过SCP2/WTAP/ABCA1途径抑制巨噬细胞脂质蓄积和动脉粥样硬化[D]: [博士学位论文]. 衡阳: 南华大学, 2023.
|
|
[12]
|
Yaşar, E. and Bayramoğlu, A. (2022) Systemic Immune-Inflammation Index as a Predictor of Microvascular Dysfunction in Patients with Cardiac Syndrome X. Angiology, 73, 615-621. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
叶雪瑞, 万秋华, 杨鑫伟, 等. 单核细胞/高密度脂蛋白胆固醇比值与冠心病相关性的研究进展[J]. 中国医药科学, 2024, 14(8): 37-40, 117.
|
|
[14]
|
黄积章. NLR、MHR与冠心病患者冠脉病变程度及GRACE评分的相关性研究[D]: [硕士学位论文]. 桂林: 桂林医学院, 2021.
|
|
[15]
|
刘成, 刘森, 杨红, 等. THR、MHR和NHR对冠状动脉狭窄程度和行PCI的预测价值[J]. 西安交通大学学报(医学版), 2024, 45(6): 948-953.
|
|
[16]
|
张玉, 包金丽. MHR与冠心病严重程度及预后的关系[J]. 心血管病防治知识, 2025, 15(4): 140-144.
|
|
[17]
|
Hu, B., Yang, X., Xu, Y., Sun, Y., Sun, C., Guo, W., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Gur, D.O., Efe, M.M., Alpsoy, S., et al. (2022) Systemic Immune-Inflammatory Index as a Determinant of Atherosclerotic Burden and High-Risk Patients with Acute Coronary Syndromes. Arquivos Brasileiros de Cardiologia, 119, 382-390.
|
|
[19]
|
张长兵, 汪欣, 胡剑平, 等. 免疫炎症指数、CRP/HDL-C与老年ACS严重程度的相关性[J]. 心血管康复医学杂志, 2022, 31(2): 160-165.
|
|
[20]
|
Liao, M., Liu, L., Bai, L., Wang, R., Liu, Y., Zhang, L., et al. (2024) Correlation between Novel Inflammatory Markers and Carotid Atherosclerosis: A Retrospective Case-Control Study. PLOS ONE, 19, e0303869. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Liuizė (Abramavičiūtė), A., Mongirdienė, A. and Laukaitienė, J. (2024) Relationship between Inflammatory Readings and the Degree of Coronary Atherosclerosis (Pilot Study). Journal of Clinical Medicine, 14, Article 122. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Özkan, U., Gürdoğan, M., Öztürk, C., Demir, M., Akkuş, Ö.F., Yılmaz, E., et al. (2022) Systemic Immune-Inflammation Index: A Novel Predictor of Coronary Thrombus Burden in Patients with Non-St Acute Coronary Syndrome. Medicina, 58, Article 143. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
陈艳丽, 帕尔哈提∙吐尔逊. 系统免疫炎症指数与心血管疾病相关性研究进展[J]. 兵团医学, 2023, 21(2): 52-55.
|
|
[24]
|
Liu, Y., Niu, P., Yan, J., Ji, H., Wang, Z., Jin, X., et al. (2024) Efficacy and Safety of Ginkgo Biloba Extract in the Treatment of Unstable Angina Pectoris: A Systematic Review and Network Meta-Analysis. Journal of Ethnopharmacology, 331, Article ID: 118297. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
沈笑然, 卢丹, 袁慧. 外周血炎症因子异常表达与不稳定型心绞痛的关联性研[J]. 中西医结合心血管病电子杂志, 2022, 10(5): 128-131.
|
|
[26]
|
Tok, D., Turak, O., Yayla, Ç., Ozcan, F., Tok, D. and Çağlı, K. (2016) Monocyte to HDL Ratio in Prediction of BMS Restenosis in Subjects with Stable and Unstable Angina Pectoris. Biomarkers in Medicine, 10, 853-860. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Meng, H., Zhou, X., Li, L., Liu, Y., Liu, Y. and Zhang, Y. (2024) Monocyte to High-Density Lipoprotein Cholesterol Ratio Predicts Restenosis of Drug-Eluting Stents in Patients with Unstable Angina Pectoris. Scientific Reports, 14, Article No. 30175. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Candemir, M., Kiziltunç, E., Nurkoç, S. and Şahinarslan, A. (2021) Relationship between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease. Angiology, 72, 575-581. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
刘尊腾, 谢骞, 刘芬, 等. SII对血流动力学紊乱的稳定型心绞痛患者不良心血管事件的预测作用[J]. 临床心血管病杂志, 2024, 40(9): 712-718.
|
|
[30]
|
张忠满, 朱轶, 陈旭锋, 等. 全身免疫炎症指数对非ST段抬高型心肌梗死患者早期发生急性心力衰竭的预测价值[J]. 南京医科大学学报(自然科学版), 2025, 45(3): 382-388.
|
|
[31]
|
Zhang, W., Jia, H., Zhao, X., Song, W., Sun, W., Wang, Q., et al. (2025) Predictive Value of Cumulative SII for MACE in STEMI Patients after PCI. Medicine, 104, e41983. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
林欣. 探究单核细胞计数/高密度脂蛋白对冠脉支架植入术后再狭窄的影响[D]: [硕士学位论文]. 长春: 吉林大学, 2019.
|
|
[33]
|
熊伶俐, 蒋学俊, 陈俊, 等. 单核细胞数与HDL-C比值预测支架内再狭窄的价值[J]. 临床心血管病杂志, 2017, 33(10): 950-953.
|
|
[34]
|
马伟利, 刘奇峰, 宝凤梅, 等. NLR和MHR及二者联合在诊断冠心病患者行经皮冠状动脉介入术后发生支架内再狭窄中的应用价值[J]. 广西医学, 2021, 43(8): 913-916.
|
|
[35]
|
Pelliccia, F., Zimarino, M., Niccoli, G., Morrone, D., De Luca, G., Miraldi, F., et al. (2023) In-Stent Restenosis after Percutaneous Coronary Intervention: Emerging Knowledge on Biological Pathways. European Heart Journal Open, 3, oead083. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Wang, H., Yang, Y., Zeng, P., Huang, R., Cai, X., Shao, L., et al. (2024) Association between Systemic Immune-Inflammation Index (SII) and New-Onset In-Hospital Heart Failure in Patients with STEMI after Primary PCI. Reviews in Cardiovascular Medicine, 25, Article 382. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
韦山, 龙曼云, 班华山, 等. 全身免疫炎症指数、SYNTAX评分和脂蛋白a水平对老年冠心病患者PCI术后发生支架内再狭窄的评估价值[J]. 广西医学, 2024, 46(6): 815-822.
|
|
[38]
|
黄滨. 新型血清炎症指标(SII、SIRI)及LP(a)与PCI术后支架内再狭窄的相关性研究[D]: [硕士学位论文]. 南昌: 南昌大学, 2024.
|
|
[39]
|
杨玉书, 张翠, 张丹, 等. 冠心病病人全身免疫炎症指数及NHR与支架内再狭窄的关系[J]. 中西医结合心脑血管病杂志, 2023, 21(17): 3221-3225.
|
|
[40]
|
Hinton, A., Claypool, S.M., Neikirk, K., Senoo, N., Wanjalla, C.N., Kirabo, A., et al. (2024) Mitochondrial Structure and Function in Human Heart Failure. Circulation Research, 135, 372-396. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Kuwahara, F., Kai, H., Tokuda, K., Niiyama, H., Tahara, N., Kusaba, K., et al. (2003) Roles of Intercellular Adhesion Molecule-1 in Hypertensive Cardiac Remodeling. Hypertension, 41, 819-823. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Vogel, C. (2020) The Role of Complement in Myocardial Infarction Reperfusion Injury: An Underappreciated Therapeutic Target. Frontiers in Cell and Developmental Biology, 8, Article 606407. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
赵亚楠. SII、TyG指数与慢性心力衰竭的相关性研究[D]: [硕士学位论文]. 唐山: 华北理工大学, 2024.
|
|
[44]
|
Baubonis, E., Laukaitienė, J., Grabauskytė, I. and Mongirdienė, A. (2025) SII, SIRI, and MHR as Additional Readings for Personalized Evaluation of Chronic Heart Failure Severity. International Journal of Molecular Sciences, 26, Article 5190. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
王凤娇. SII、SIRI、AISI、IL-6与心力衰竭患者房颤发生的相关性研究[D]: [硕士学位论文]. 青岛: 青岛大学, 2024.
|
|
[46]
|
成维梦, 李天玥, 张颖, 等. 单核细胞与高密度脂蛋白比值与急性失代偿性心力衰竭患者临床预后的相关性研究[J]. 临床心血管病杂志, 2023, 39(10): 774-781.
|
|
[47]
|
孙红春, 李敬, 高茜, 等. 沙库巴曲缬沙坦和托伐普坦对慢性心力衰竭急性发作患者炎性指标的影响[J]. 中华老年心脑血管病杂志, 2023, 25(5): 469-472.
|
|
[48]
|
Marchi, F., Pylypiv, N., Parlanti, A., Storti, S., Gaggini, M., Paradossi, U., et al. (2024) Systemic Immune-Inflammation Index and Systemic Inflammatory Response Index as Predictors of Mortality in ST-Elevation Myocardial Infarction. Journal of Clinical Medicine, 13, Article 1256. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Yayla, K.G., Canpolat, U., Yayla, Ç., et al. (2017) A Novel Marker of Impaired Aortic Elasticity in Never Treated Hypertensive Patients: Monocyte/High-Density Lipoprotein Cholesterol Ratio. Acta Cardiological Sinica, 33, 41-49.
|
|
[50]
|
Wang, L., Liu, Y., Shi, W., Liu, X. and Qin, M. (2024) Value of the Monocyte‐To‐High‐Density Lipoprotein Cholesterol Ratio in Refining the Detection of Prevalent Heart Failure: Insights from the NHANES 1999-2018. Lipids, 59, 93-100. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Yuan, M., Ren, F. and Gao, D. (2022) The Value of SII in Predicting the Mortality of Patients with Heart Failure. Disease Markers, 2022, Article ID: 3455372. [Google Scholar] [CrossRef] [PubMed]
|
|
[52]
|
Madhur, M.S., Elijovich, F., Alexander, M.R., Pitzer, A., Ishimwe, J., Van Beusecum, J.P., et al. (2021) Hypertension: Do Inflammation and Immunity Hold the Key to Solving This Epidemic? Circulation Research, 128, 908-933. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Norlander, A.E., Madhur, M.S. and Harrison, D.G. (2017) The Immunology of Hypertension. Journal of Experimental Medicine, 215, 21-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[54]
|
Agita, A. and Alsagaff, M.T. (2017) Inflammation, Immunity, and Hypertension. Acta Medica Indonesiana, 49, 158-165.
|
|
[55]
|
Liu, X., Zhang, Y., Jin, F,. et al. (2021) Correlation between GPR, MHR and Elderly Essential Hypertension with Unstable Angina Pectoris. Journal of Central South University. Medical Sciences, 46, 373-378.
|
|
[56]
|
马庆华, 孟翠巧, 李刚. 单核细胞/高密度脂蛋白胆固醇比值与原发性高血压患者发生左心房增大的关系[J]. 中华高血压杂志(中英文), 2024, 32(11): 1043-1048.
|
|
[57]
|
Lu, X., Rudemiller, N.P., Wen, Y., Ren, J., Hammer, G.E., Griffiths, R., et al. (2019) A20 in Myeloid Cells Protects against Hypertension by Inhibiting Dendritic Cell-Mediated T-Cell Activation. Circulation Research, 125, 1055-1066. [Google Scholar] [CrossRef] [PubMed]
|
|
[58]
|
张丹, 李宏飞, 闫梅, 等. 原发性高血压患者血清胱抑素C、同型半胱氨酸与靶器官损害的关系[J]. 岭南心血管病杂志, 2022, 28(6): 540-544.
|
|
[59]
|
李政贤, 周白丽. 西宁地区原发性高血压患者血清MHR、NMLR、Ca/Mg的临床意义[J]. 实用心电学杂志, 2024, 33(1): 24-28.
|
|
[60]
|
GEMBILLO, G., Siligato, R., Cernaro, V., Satta, E., Conti, G., Salvo, A., et al. (2020) SAT-144 Monocyte to HDL Ratio: A Novel Marker of Resistant Hypertension in CKD Patients. Kidney International Reports, 5, S61-S62. [Google Scholar] [CrossRef]
|
|
[61]
|
Zhang, Y., Ding, Y. and Jiang, W. (2023) Neutrophil and Monocyte Ratios to High-Density Lipoprotein Cholesterol as Biomarkers in Non-Dipping Hypertension. Clinical and Experimental Hypertension, 45, Article ID: 2210785. [Google Scholar] [CrossRef] [PubMed]
|
|
[62]
|
Sun, M., Liang, C., Lin, H., Meng, Y., Tang, Q., Shi, X., et al. (2021) Monocyte to HDL Cholesterol Ratio as a Marker of the Presence and Severity of Obstructive Sleep Apnea in Hypertensive Patients. Scientific Reports, 11, Article No. 15821. [Google Scholar] [CrossRef] [PubMed]
|
|
[63]
|
Zhang, P., Song, X., Li, W., Wei, J., Cui, Y., Qi, Y., et al. (2022) Study on the Mechanism of Bu-Shen-He-Mai Granules in Improving Renal Damage of Ageing Spontaneously Hypertensive Rats by Regulating Th17 Cell/Tregs Balance. Evidence-Based Complementary and Alternative Medicine, 2022, 1-15. [Google Scholar] [CrossRef] [PubMed]
|
|
[64]
|
Aljuraiban, G.S., Alharbi, F.J., Aljohi, A.O., Almeshari, A.Z., Alsahli, A.S., Alotaibi, B.S., et al. (2024) Systemic Immune-Inflammation Index and Its Relation to Blood Pressure and Dyslipidemia in Adults: A Retrospective Study. Medicine, 103, e38810. [Google Scholar] [CrossRef] [PubMed]
|
|
[65]
|
Aydin, C., Alpsoy, Ş., Akyüz, A., Özkaramanli Gür, D., Emlek, N., Şahin, A., et al. (2021) Could the Systemic Immune-Inflammation Index Be a Predictor to Estimate Cerebrovascular Events in Hypertensive Patients? Blood Pressure Monitoring, 27, 33-38. [Google Scholar] [CrossRef] [PubMed]
|
|
[66]
|
Ma, L., Xiao, H., Zhang, J., Liu, Y., Hu, L., Chen, N., et al. (2024) Association between Systemic Immune Inflammatory/Inflammatory Response Index and Hypertension: A Cohort Study of Functional Community. Nutrition, Metabolism and Cardiovascular Diseases, 34, 334-342. [Google Scholar] [CrossRef] [PubMed]
|
|
[67]
|
Baskovski, E., Altin, T., Akyurek, O., Cunetoglu, M.E., Tan, T.S., Kurklu, H.A., et al. (2025) Systemic Immune-Inflammatory Index and Other Inflammatory Markers in Electrical Storm Vs. Patients Undergoing Elective Ventricular Tachycardia Ablation. Postgraduate Medicine, 137, 543-551. [Google Scholar] [CrossRef] [PubMed]
|
|
[68]
|
Ömür, S.E. (2023) Comparison of the Relationship between Inflammatory Markers and Atrial Fibrillation Burden. The Anatolian Journal of Cardiology, 27, 488-493. [Google Scholar] [CrossRef] [PubMed]
|
|
[69]
|
Chen, S., Zhang, M., Zheng, M., Liu, F., Sun, L., Bao, Z., et al. (2020) The Preablation Monocyte/High Density Lipoprotein Ratio Predicts the Late Recurrence of Paroxysmal Atrial Fibrillation after Radiofrequency Ablation. BMC Cardiovascular Disorders, 20, Article No. 401. [Google Scholar] [CrossRef] [PubMed]
|
|
[70]
|
Kutlay, Ö., Yalım, Z. and Aktan, A.K. (2023) Inflammatory Biomarkers Derived from Whole Blood Cell Count in Atrial Fibrillation Patients. Kardiologiia, 63, 50-55. [Google Scholar] [CrossRef] [PubMed]
|
|
[71]
|
Koca, F., Levent, F., Sensoy, B. and Tenekecioglu, E. (2023) The Predictive Value of the Systemic Immune-Inflammatory Index for Left Atrial Appendage Thrombus in Non-Valvular Atrial Fibrillation. Biomedical Papers, 167, 162-168. [Google Scholar] [CrossRef] [PubMed]
|
|
[72]
|
Naser, A., Sayilan, S., Güven, O., Şengör, B.G., Biçici, A., Uzun, Y., et al. (2024) Inflammation Burden and Atrial Fibrillation Burden: A Bidirectional Relationship. Arquivos Brasileiros de Cardiologia, 121, e20230680. [Google Scholar] [CrossRef]
|